2011 Annual Meeting

Session: Model Based QbD In Drug Substance or Drug Product Development

Chair

Marek, J., Abbott Laboratories

Co-Chair

Presentations

12:30 PM

(701a) Modeling a Reactive Crystallization with a Reduced Population Balance Equation for Dissolution and Growth to Control Critical Quality Attributes

12:50 PM

(701b) Model-Based Characterisation of Organic and Aqueous Tablet Film Coating Processes: Parameter Estimation and Risk Management

01:10 PM

(701c) Design Space Verification for Tablet Dosage Form Using Modeling

01:30 PM

(701d) New Model-Based Platform for Enhanced Content Uniformity Prediction of Oral Dosage Forms

01:55 PM

(701e) Computation of Reliabilities for Extent of Reactant Conversion Incorporating Batch Effects with Applications to ICH Q8 Design Space

02:15 PM

(701f) Estimating Reaction Model Uncertainty with Bayesian Markov Chain Monte Carlo

02:35 PM

(701g) Controllability Analysis of Protein Glycosylation In CHO Cells